Submission Details
| 510(k) Number | K213007 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 20, 2021 |
| Decision Date | July 06, 2022 |
| Days to Decision | 289 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K213007 is an FDA 510(k) clearance for the Cerebra Sleep System, a Standard Polysomnograph With Electroencephalograph (Class II — Special Controls, product code OLV), submitted by Cerebra Medical , Ltd. (Winnipeg, CA). The FDA issued a Cleared decision on July 6, 2022, 289 days after receiving the submission on September 20, 2021. This device falls under the Neurology review panel. Regulated under 21 CFR 882.1400.
| 510(k) Number | K213007 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 20, 2021 |
| Decision Date | July 06, 2022 |
| Days to Decision | 289 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | OLV — Standard Polysomnograph With Electroencephalograph |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.1400 |
| Definition | Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain And Other Signals (such As Electromyography, Respiratory And/or Oximetry Signals) For Sleep Recordings. May Also Be Used To Allow On-screen Review, User-controlled Annotation And User-controlled Marking Of Data. |